Taha Bat

Dr. Taha Bat

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2021 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
DWDaniel Welder
Daniel Welder
HJHaekyung Jeon‐Slaughter
Haekyung Jeon‐Slaughter
BABilal Ashraf
Bilal Ashraf
SCSung‐Hee Choi
Sung‐Hee Choi
WCWeina Chen
Weina Chen
TBTaha Bat
Taha Bat
Summary: COVID‐19, caused by SARS‐CoV‐2, is a contagious life‐threatening viral disease that has killed more than three million people worldwide to date. Attempts have been made to identify biomarker(s) to stratify disease severity and improve treatment and resource allocation. Patients with SARS‐COV‐2 infection manifest with a higher inflammatory response and platelet hyperreactivity; this raises the question of the role of thrombopoiesis in COVID‐19 infection. Immature platelet fraction (IPF, %) and immature platelet counts (IPC, ×109/l) can be used to assess thrombopoiesis. This study investigates whether the level of thrombopoiesis correlates with COVID‐19 severity. A large cohort of 678 well‐characterized COVID‐19 patients was analyzed, including 658 (97%) hospitalized and 139 (21%) admitted to the intensive care unit (ICU). Elevated percentage IPF at presentation was predictive of length of hospitalization (P < 0·01) and ICU admission (P < 0·05). Additionally, percentage IPF at the peak was significantly higher among ICU patients than non‐ICU patients (6·9 ± 5·1 vs 5·3 ± 8·4, P < 0·01) and among deceased patients than recovered patients (7·9 ± 6·3 vs 5·4 ± 7·8, P < 0·01). Furthermore, IPC at the peak was significantly higher among ICU patients than non‐ICU patients (18·5 ± 16·2 vs. 13·2 ± 8·3, P < 0·05) and among patients on a ventilator than those not (22·1 ± 20·1 vs.13·4 ± 8·4, P < 0·05). Our study demonstrated that elevated initial and peak values of percentage IPF and IPC might serve as prognostic biomarkers for COVID‐19 progression to severe conditions.

7 March 2023 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
GRGanesh Raman
Ganesh Raman
BABilal Ashraf
Bilal Ashraf
YDYusuf Kemal Demir
Yusuf Kemal Demir
CKCorey D. Kershaw
Corey D. Kershaw
SCSreekanth Cheruku
Sreekanth Cheruku
MMMutlu Mete
Mutlu Mete
Importance: Early prognostication of patients hospitalized with COVID-19 who may require mechanical ventilation and have worse outcomes within 30 days of admission is useful for delivering appropriate clinical care and optimizing resource allocation. Objective: To develop machine learning models to predict COVID-19 severity at the time of the hospital admission based on a single institution data. Design, setting, and participants: We established a retrospective cohort of patients with COVID-19 from University of Texas Southwestern Medical Center from May 2020 to March 2022. Easily accessible objective markers including basic laboratory variables and initial respiratory status were assessed using Random Forest’s feature importance score to create a predictive risk score. Twenty-five significant variables were identified to be used in classification models. The best predictive models were selected with repeated tenfold cross-validation methods. Main outcomes and measures: Among patients with COVID-19 admitted to the hospital, severity was defined by 30-day mortality (30DM) rates and need for mechanical ventilation. Results: This was a large, single institution COVID-19 cohort including total of 1795 patients. The average age was 59.7 years old with diverse heterogeneity. 236 (13%) required mechanical ventilation and 156 patients (8.6%) died within 30 days of hospitalization. Predictive accuracy of each predictive model was validated with the 10-CV method. Random Forest classifier for 30DM model had 192 sub-trees, and obtained 0.72 sensitivity and 0.78 specificity, and 0.82 AUC. The model used to predict MV has 64 sub-trees and returned obtained 0.75 sensitivity and 0.75 specificity, and 0.81 AUC. Our scoring tool can be accessed at https://faculty.tamuc.edu/mmete/covid-risk.html. Conclusions and relevance: In this study, we developed a risk score based on objective variables of COVID-19 patients within six hours of admission to the hospital, therefore helping predict a patient's risk of developing critical illness secondary to COVID-19.

1 July 2022 in Blood Advances
Verified
Journal Article
Open access
PDF file
NLNicholas C. J. Lee
Nicholas C. J. Lee
BPBhavisha Patel
Bhavisha Patel
AEAaron Etra
Aaron Etra
TBTaha Bat
Taha Bat
IIIbrahim F. Ibrahim
Ibrahim F. Ibrahim
WCWeina Chen
Weina Chen

14 August 2017 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
TBTaha Bat
Taha Bat
OAOmnia N. Abdelhamid
Omnia N. Abdelhamid
SBSuresh K. Balasubramanian
Suresh K. Balasubramanian
AMAly Mai
Aly Mai
TRTomas Radivoyevitch
Tomas Radivoyevitch
JMJaroslaw P. Maciejewski
Jaroslaw P. Maciejewski

1 January 2024 in Therapeutic Advances in Hematology
Verified
Journal Article
Open access
JSJulia J. Shi
Julia J. Shi
YOYusuf M. Ozcan
Yusuf M. Ozcan
CSCarlos I. Ayala Santos
Carlos I. Ayala Santos
HPHetalkumari Patel
Hetalkumari Patel
JSJamile Shammo
Jamile Shammo
TBTaha Bat
Taha Bat
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder which is caused by mutations in phosphatidylinositol glycan class A leading to hemolysis of red blood cells via complement inhibition. The first treatment for PNH, eculizumab, was FDA approved in 2007. Since then, many new treatment options for PNH have arisen. This critical review will examine all medications available for PNH on the US market, highlight several major medications in development, and discuss the risks and treatment considerations associated with each option. It is not intended to address PNH clonal dynamics, disease presentation, or discussions on when to initiate treatment.

12 March 2024 in British Journal of Haematology
Verified
Journal Article
Closed access
ZTZehra Tombul
Zehra Tombul
WBWaled Bahaj
Waled Bahaj
MOMerve Ozturk
Merve Ozturk
BPBhavisha Patel
Bhavisha Patel
ATAhmet Toprak
Ahmet Toprak
TBTaha Bat
Taha Bat